Showing results (901-910 of 2,466) with videos related to
Sort By:
Pageof 247
Cancer Treatment Reviews|December 16, 2014
Emerging therapeutic targets in bladder cancerBenedito A Carneiro, Joshua J Meeks, Timothy M Kuzel, et al.Cancer Treatment Reviews|September 15, 2014
Prognostic relevance of receptor tyrosine kinase expression in breast cancer: a meta-analysisArnoud J Templeton, Laura Diez-Gonzalez, Olga Ace, et al.Cancer Treatment Reviews|January 13, 2015
A systematic review of factors influencing older adults' decision to accept or decline cancer treatmentMartine T E Puts, Brianne Tapscott, Margaret Fitch, et al.Cancer Treatment Reviews|January 13, 2015
Drug radiotherapy combinations: review of previous failures and reasons for future optimismGeoff S Higgins, Sean M O'Cathail, Ruth J Muschel, et al.Cancer Treatment Reviews|August 20, 2017
Beyond genomics - Targeting the epigenome in diffuse large B-cell lymphomaAndrea Kühnl, David Cunningham, Ian ChauCancer Treatment Reviews|August 15, 2017
Outcome of patients with lung adenocarcinoma with transformation to small-cell lung cancer following tyrosine kinase inhibitors treatment: A systematic review and pooled analysisElisa Roca, Cristina Gurizzan, Vito Amoroso, et al.Cancer Treatment Reviews|September 4, 2017
Interleukin-8 in cancer pathogenesis, treatment and follow-upCarlos Alfaro, Miguel F Sanmamed, María E Rodríguez-Ruiz, et al.Cancer Treatment Reviews|October 8, 2015
Mechanisms and latest clinical studies of new NK1 receptor antagonists for chemotherapy-induced nausea and vomiting: Rolapitant and NEPA (netupitant/palonosetron)Camilo Rojas, Barbara S SlusherCancer Treatment Reviews|June 5, 2016
Can the response to a platinum-based therapy be predicted by the DNA repair status in non-small cell lung cancer?Marianna Macerelli, Monica Ganzinelli, Cedric Gouedard, et al.Cancer Treatment Reviews|June 26, 2016
Do platinum salts fit all triple negative breast cancers?L Gerratana, V Fanotto, G Pelizzari, et al.Pageof 247